PV Bulletin

Omnipod Insulin Management System Recall in Canada

Health Canada posted a recall for Omnipod Insulin Management System due to product performance issues.

Primary source: Health Canada

PV Impact Brief

Urgency: HighConfidence: high

What changed

Health Canada announced a recall for Omnipod Insulin Management System due to product performance issues.

Why it matters

Product performance issues may lead to insulin delivery errors, posing serious health risks to users.

Action needed

Identify affected lots and implement recall procedures as per Health Canada guidelines.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

action required within 24 hours

Regulatory action details

Action type
Health product recall
Publication date
2026-06-01
Safety issue
Recall for Omnipod Insulin Management System due to product performance issues.

Affected products

  • Omnipod Insulin Management System
    Insulet Corporation

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 1, 2026

Full briefing

Practical implication

Identify affected lots and implement recall procedures as per Health Canada guidelines.

Recall for Omnipod Insulin Management System due to product performance issues.

What changed: Health Canada announced a recall for Omnipod Insulin Management System due to product performance issues.

Why it matters: Product performance issues may lead to insulin delivery errors, posing serious health risks to users.

Practical implication: Identify affected lots and implement recall procedures as per Health Canada guidelines.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Health Canada#Safety Signal#Safety Signals#firecrawl-agent#regulatory-extraction#Health Product Recall

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward